Patrick Morgan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Patrick Morgan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
A. Vento
1 shared publication- Andrew Rhodes
Department of Critical Care, St George’s University Hospitals NHS Foundation Trust, London SW17 0QT, UK
1 shared publication - Anne Ristikankare
Department of Anaesthesiology and Intensive Care, Helsinki University Central Hospital, Helsinki, Finland
1 shared publication F. Flynn
London, UK
1 shared publicationL. Uotila
1 shared publicationM. Georghiou
London, UK
1 shared publication
Latest Publications
- 1 June 2008
- Published by Wolters Kluwer Health in Current Opinion in Critical Care
- Vol. 14 (3) , 322-326
Minimally invasive cardiac output monitoring
The measurement of cardiac output in the critically ill constitutes a vital part in the management of these patients. Minimally invasive techniques are gaining popularity as they allow continuous cardiac output monitoring while avoiding the risks associated with pulmonary artery catheterization. This article focuses on some of the commonly used minimally invasive devices that rely on pulse contour waveform analysis. The current studies in the literature that assess the validity and the clinical applications of calibrated and noncalibrated arterial waveform derived cardiac output devices are discussed. The minimally invasive cardiac output monitoring devices available differ in their methodology and application. Currently there is conflicting evidence as to the accuracy of some of these systems and further investigation into their clinical application is required.
- 1 June 2008
- Published by Wolters Kluwer Health in Current Opinion in Critical Care
- Vol. 14 (3) , 322-326
Minimally invasive cardiac output monitoring
The measurement of cardiac output in the critically ill constitutes a vital part in the management of these patients. Minimally invasive techniques are gaining popularity as they allow continuous cardiac output monitoring while avoiding the risks associated with pulmonary artery catheterization. This article focuses on some of the commonly used minimally invasive devices that rely on pulse contour waveform analysis. The current studies in the literature that assess the validity and the clinical applications of calibrated and noncalibrated arterial waveform derived cardiac output devices are discussed. The minimally invasive cardiac output monitoring devices available differ in their methodology and application. Currently there is conflicting evidence as to the accuracy of some of these systems and further investigation into their clinical application is required.
- Open Access
- 1 July 2007
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 99 (1) , 143-144
Lack of renoprotective effect of i.v. N -acetylcysteine in patients with chronic renal failure
Editor—We read with interest the paper by Ristikankare and colleagues1 regarding the lack of renoprotective effect of N-acetylcysteine (NAC) in patients with pre-existing renal failure undergoing cardiac surgery. We feel that several aspects of this study require further comment. First, a recent meta-analysis of the use of NAC to prevent contrast-induced nephropathy in patients with renal impairment was inconclusive,2 therefore, reducing the evidence base for the rational use of NAC. We would also wish to question the inclusion of patients with plasma creatinine greater than 100 µmol litre−1, which is below the upper limit of normal for many laboratory results in the UK. Therefore, it seems likely that this study may have included patients with normal renal function. We suggest it would have been more appropriate to identify patients with established renal impairment using a more specific measure than plasma creatinine, such as Glomerular Filtration Rate or estimated creatinine clearance.3
- 1 July 2007
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 99 (1) , 143-144
Open AccessLack of renoprotective effect of i.v. N -acetylcysteine in patients with chronic renal failure
Editor—We read with interest the paper by Ristikankare and colleagues1 regarding the lack of renoprotective effect of N-acetylcysteine (NAC) in patients with pre-existing renal failure undergoing cardiac surgery. We feel that several aspects of this study require further comment. First, a recent meta-analysis of the use of NAC to prevent contrast-induced nephropathy in patients with renal impairment was inconclusive,2 therefore, reducing the evidence base for the rational use of NAC. We would also wish to question the inclusion of patients with plasma creatinine greater than 100 µmol litre−1, which is below the upper limit of normal for many laboratory results in the UK. Therefore, it seems likely that this study may have included patients with normal renal function. We suggest it would have been more appropriate to identify patients with established renal impairment using a more specific measure than plasma creatinine, such as Glomerular Filtration Rate or estimated creatinine clearance.3